Katja Kaipio
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Ovarian cancer diagnosis and treatment, Lung Cancer Research Studies, Peptidase Inhibition and Analysis, Cancer Genomics and Diagnostics
Most-Cited Works
- → Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer(2022)194 cited
- → Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance(2021)168 cited
- → Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans 1(2001)119 cited
- → A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer Patients(2018)112 cited
- → A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids(2023)106 cited
- → FHOD1, a Formin Upregulated in Epithelial-Mesenchymal Transition, Participates in Cancer Cell Migration and Invasion(2013)70 cited
- → Transgenic Mice Overexpressing Neuropeptide Y in Noradrenergic Neurons(2008)60 cited
- → ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors(2019)53 cited
- → PRISM: recovering cell-type-specific expression profiles from individual composite RNA-seq samples(2021)45 cited
- → Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells(2019)42 cited